Showing 26–50 of 51 · Clinical AI & decision support
FY2026 revenue $331.84bn (+18.0%); operating margin 46.8%; net income $133.75bn.
Balance sheet figures not captured from release.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent Microsoft (MSFT) group FY2026 revenue $331.84bn (+18.0%); operating margin 46.8%; net income $133.75bn.
Figures cover the whole listed group, not this business alone.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue €17.83bn (-1.0%); operating margin 8.0%; net income €895.0m.
Net debt €5.29bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue SEK 1.34bn (+12.8%); operating margin 21.7%; net income SEK 228.0m.
Balance sheet figures not captured from release.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue €23.60bn; adjusted EBIT margin 16.2%.
Comparable revenue growth 4.0%; adjusted EBIT about €3.8bn. Net income not captured.
FY2025 revenue $8.32bn (+0.9%); operating margin 26.2%; net income $1.56bn.
Cash $878.0m; debt $5.04bn.
FY2025 revenue $77.3m (+19.0%); operating margin -91.7%; net loss $79.0m.
Balance sheet figures not captured from release.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $1.27bn (+83.4%); operating margin -19.9%; net loss $245.0m.
Cash $759.7m; debt $1.24bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Listed (338220.KQ).
Latest full-year results not yet captured by HSH.
Parent Wolters Kluwer (WKL.AS) group FY2025 revenue €6.12bn (+3.5%); operating margin 28.3%; net income €1.31bn.
Health division revenue €1.60bn (+5% organic); net debt €4.02bn.